The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 1];10(2):s767. Available from: https://skin.dermsquared.com/skin/article/view/4122